AROMICS has a clear international vision. From its inception, the company has participated in the establishment of a biotechnology strategy in Europe to improve commercial and production activities of small and medium size companies.
AROMICS has proven experience in R&D Projects under various funding programs: European (Horizon 2020), national (CDTI) and local (ACC1Ó-FEDER). The active participation of the company in European funded R&D projects as well as membership in different European platforms enables the company to:
- Be at the forefront of European research.
- Identify, improve and implant new technologies with potential applications in the health sector(industry and clinical practice).
- Favor technology transfer.
- Share the costs of innovation through partnerships with other biotechnology and pharmaceutical companies.